VMPIC
ALNY icon

Varma Mutual Pension Insurance Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Varma Mutual Pension Insurance Co’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,100
Closed -$6.98M – 315
2026
Q1 		$6.98M Sell
21,100
-5,000
-19% -$1.7M 0.04% 292
2025
Q4 		$10.4M Buy
+26,100
New +$11.6M 0.06% 262
2022
Q1 		– Sell
-20,000
Closed -$3.39M – 207
2021
Q4 		$3.39M Buy
+20,000
New +$3.72M 0.05% 156

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Varma Mutual Pension Insurance Co's ALNY Position: Q2 2026 in Review

Varma Mutual Pension Insurance Co sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 21,100 shares — an estimated $6.98M sold.

Varma Mutual Pension Insurance Co first reported a position in ALNY in Q4 2021 and held it in 3 quarters. The position peaked at $10.4M in Q4 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Varma Mutual Pension Insurance Co reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Varma Mutual Pension Insurance Co sold 21,100 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $6.98M.
  • Varma Mutual Pension Insurance Co first reported a position in Alnylam Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Varma Mutual Pension Insurance Co's Alnylam Pharmaceuticals position peaked at $10.4M in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Varma Mutual Pension Insurance Co's 13F filing for Q2 2026, filed 12 Aug 2026.